Boston biotech developing obesity drug pulls down $120M in IPO
October 05, 2017 at 06:19 AM EDT
The 9-year-old biotech company headquartered in Boston’s Back Bay, Rhythm Pharmaceuticals Inc. has become the fourth local drugmaker to go public this year, raising $120 million in an upsized public offering.
